FDA Inspection 1037302 — Louisville Reproductive Center

Louisville Reproductive Center — FEI 3005081370

The FDA completed an inspection of Louisville Reproductive Center on January 4, 2018 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 4, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Louisville, KY (United States)